Skip Navigation



ToxSci Advance Access published online on June 26, 2008

Toxicological Sciences, doi:10.1093/toxsci/kfn127
This Article
Right arrow Advance Access manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fang, X.
Right arrow Articles by Dai, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fang, X.
Right arrow Articles by Dai, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

Immunotoxic Effects of Perfluorononanoic Acid on BALB/c Mice

Xuemei Fang*,{dagger}, Lianjun Zhang{ddagger}, Yixing Feng*, Yong Zhao{ddagger} and Jiayin Dai*,§

* Key Laboratory of Animal Ecology and Conservation Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100190, China {dagger} Graduate School of the Chinese Academy of Sciences, Beijing 100080, China {ddagger} State Key Laboratory of Biomembrane and Membrane Biotechnology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100190, China

§ Corresponding author: Professor Jiayin Dai, Key Laboratory of Animal Ecology and Conservation Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, China, Tel.: +86-10-64807185, Fax: +86-10-64807099, E-mail: daijy{at}ioz.ac.cn

Received May 7, 2008; revision received June 16, 2008; accepted June 19, 2008


   Abstract

The effects of perfluorononanoic acid (PFNA) on the immune system and its mechanism of action in mice have not been elucidated. Thus, BALB/c mice were exposed to the PFNA (0, 1, 3, or 5 mg/kg/day) for fourteen days. Exposure to PFNA led to a decrease in body weight and in the weight of the lymphoid organs. Cell cycle arrest and apoptosis were observed in the spleen and thymus following PFNA exposure. In the thymus, PFNA mostly modulated CD4+CD8+ thymocytes, while the F4/80+, CD11c+, and CD49b+ cells were major targets in the spleen. Although concanavalin A (ConA)-induced T lymphocyte blastogenesis was not altered by PFNA, production of interleukin (IL)-4 and interferon-gamma (IFN{gamma}) by splenic lymphocytes was remarkably impaired. The levels of cortisol and adrenocorticotrophic hormone (ACTH) in sera were increased; however, the expression of glucocorticoid receptor (GR) in the thymus was unchanged. In addition, expression of the peroxisome proliferator-activated receptors (PPAR{alpha} and PPAR{gamma}) and IL-1β were upregulated significantly in the thymus at a dose of 1 mg PFNA/kg/day. No significant changes in expression of the inhibitory protein I{kappa}B{alpha} and I{kappa}B{alpha} kinase (IKK) were observed. Together, these results suggest that PFNA exerts toxic effects on lymphoid organs and T cell and innate immune cell homeostasis in mice and that these effects may result from the activation of PPAR{alpha}, PPAR{gamma}, and the hypothalamic-pituitary-adrenal (HPA) axis. Interestingly, at the transcriptional level, the nuclear factor-kappa B (NF-{kappa}B) signaling pathway appears to be uninvolved in the immunotoxic potential of PFNA.

Key Words: PFNA; Immunotoxicity; PPAR; glucocorticoid; NF-{kappa}B.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.